This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Jun Sub Park
Introduction
Jun Sub Park is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 analogs. With a total of two patents to his name, Park's innovations are paving the way for advancements in immunostimulation.
Latest Patents
Park's latest patents focus on immunostimulating IL-2 analogs. The first patent discloses modifications to interleukin-2 alpha receptors. Additionally, it presents interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors. The second patent also relates to changes in interleukin-2 alpha receptors and highlights the increased binding affinity for interleukin-2 beta receptors.
Career Highlights
Jun Sub Park is currently employed at Hanmi Pharm. Co., Ltd. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Euh Lim Oh and Sang Yun Kim. Their collective efforts contribute to the innovative research and development at Hanmi Pharm.
Conclusion
Jun Sub Park's contributions to immunology through his patents on interleukin-2 analogs demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile